These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 33671406)

  • 1. Treating Hyperuricemia: The Last Word Hasn't Been Said Yet.
    Russo E; Verzola D; Leoncini G; Cappadona F; Esposito P; Pontremoli R; Viazzi F
    J Clin Med; 2021 Feb; 10(4):. PubMed ID: 33671406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uric acid lowering for slowing CKD progression after the CKD-FIX trial: a solved question or still a dilemma?
    Leoncini G; Barnini C; Manco L; Nobili G; Dotta D; Penso M; Russo E; Cappadona F; Viazzi F; Pontremoli R
    Clin Kidney J; 2022 Sep; 15(9):1666-1674. PubMed ID: 36003668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent evidence on the effect of urate-lowering treatment on the progression of kidney disease.
    Tiku A; Johnson DW; Badve SV
    Curr Opin Nephrol Hypertens; 2021 May; 30(3):346-352. PubMed ID: 33767063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular Disease in Gout and the Protective Effect of Treatments Including Urate-Lowering Therapy.
    Gupta MK; Singh JA
    Drugs; 2019 Apr; 79(5):531-541. PubMed ID: 30868398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of urate-lowering agents in asymptomatic hyperuricemia: systematic review and network meta-analysis of randomized controlled trials.
    Sapankaew T; Thadanipon K; Ruenroengbun N; Chaiyakittisopon K; Ingsathit A; Numthavaj P; Chaiyakunapruk N; McKay G; Attia J; Thakkinstian A
    BMC Nephrol; 2022 Jun; 23(1):223. PubMed ID: 35739495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Urate-Lowering Therapy in Patients With Chronic Kidney Disease: A Network Meta-Analysis of Randomized Controlled Trials.
    Yu X; Gu M; Zhu Y; Zhang L; Kong W; Zou Y
    Clin Ther; 2022 May; 44(5):723-735.e6. PubMed ID: 35610080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urate-lowering agents for asymptomatic hyperuricemia in stage 3 - 4 chronic kidney disease: Controversial role of kidney function.
    Jeon HJ; Oh J; Shin DH
    PLoS One; 2019; 14(6):e0218510. PubMed ID: 31206563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Urate-Lowering Therapy on Cardiovascular and Kidney Outcomes: A Systematic Review and Meta-Analysis.
    Chen Q; Wang Z; Zhou J; Chen Z; Li Y; Li S; Zhao H; Badve SV; Lv J
    Clin J Am Soc Nephrol; 2020 Nov; 15(11):1576-1586. PubMed ID: 33055192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Management of Gout in Renal Disease.
    Estiverne C; Mount DB
    Semin Nephrol; 2020 Nov; 40(6):600-613. PubMed ID: 33678314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of Drug Treatments for Lowering Uric Acid on Renal Function in Patients With Chronic Kidney Disease and Hyperuricemia: A Network Meta-Analysis of Randomized Controlled Trials.
    Liu X; Qiu Y; Li D; Tan J; Liang X; Qin W
    Front Pharmacol; 2021; 12():690557. PubMed ID: 34413775
    [No Abstract]   [Full Text] [Related]  

  • 11. Hyperuricemia, gout and the kidney.
    Gibson T
    Curr Opin Rheumatol; 2012 Mar; 24(2):127-31. PubMed ID: 22157498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comorbidity in gout and hyperuricemia: prevalence, causes, prospects of urate lowering therapy].
    Eliseev MS; Novikova AM
    Ter Arkh; 2019 May; 91(5):120-128. PubMed ID: 32598686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperuricemia in Kidney Disease: A Major Risk Factor for Cardiovascular Events, Vascular Calcification, and Renal Damage.
    Ejaz AA; Nakagawa T; Kanbay M; Kuwabara M; Kumar A; Garcia Arroyo FE; Roncal-Jimenez C; Sasai F; Kang DH; Jensen T; Hernando AA; Rodriguez-Iturbe B; Garcia G; Tolan DR; Sanchez-Lozada LG; Lanaspa MA; Johnson RJ
    Semin Nephrol; 2020 Nov; 40(6):574-585. PubMed ID: 33678312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urate-Lowering Agents in Asymptomatic Hyperuricemia: Role of Urine Sediment Analysis and Musculoskeletal Ultrasound.
    Viggiano D; Gigliotti G; Vallone G; Giammarino A; Nigro M; Capasso G
    Kidney Blood Press Res; 2018; 43(2):606-615. PubMed ID: 29689561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effect of allopurinol and febuxostat on long-term renal outcomes in patients with hyperuricemia and chronic kidney disease: a systematic review.
    Hu AM; Brown JN
    Clin Rheumatol; 2020 Nov; 39(11):3287-3294. PubMed ID: 32418037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Establishment of therapeutic goal and plan of gout and asymptomatic hyperuricemia].
    Fujimori S
    Nihon Rinsho; 2008 Apr; 66(4):729-35. PubMed ID: 18409523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uric acid lowering therapies for preventing or delaying the progression of chronic kidney disease.
    Sampson AL; Singer RF; Walters GD
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD009460. PubMed ID: 29084343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. To Treat or Not to Treat? Effect of Urate-Lowering Therapy on Renal Function, Blood Pressure and Safety in Patients with Asymptomatic Hyperuricemia: A Systematic Review and Network Meta-Analysis.
    Tien YY; Shih MC; Tien CP; Huang HK; Tu YK
    J Am Board Fam Med; 2022; 35(1):140-151. PubMed ID: 35039419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between urate-lowering therapies and treatment-related adverse events, liver damage, and major adverse cardiovascular events (MACE): A network meta-analysis of randomized trials.
    Zhang S; Xie Q; Xie S; Chen J; Deng Q; Zhong L; Guo J; Yu Y
    Pharmacotherapy; 2021 Sep; 41(9):781-791. PubMed ID: 34170566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urate lowering therapy to improve renal outcomes in patients with chronic kidney disease: systematic review and meta-analysis.
    Kanji T; Gandhi M; Clase CM; Yang R
    BMC Nephrol; 2015 Apr; 16():58. PubMed ID: 25928556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.